<?xml version="1.0" encoding="utf-8"?> <rss version="2.0" xml:base="https://www.mobihealthnews.com" xmlns:dc="http://purl.org/dc/elements/1.1/"> <channel> <title>MobiHealthNews - Viz.ai</title> <link>https://www.mobihealthnews.com/tag/vizai</link> <description></description> <language>en</language> <item> <title>Telehealth use for behavioral health increases 45X since pandemic onset and more digital health briefs</title> <link>https://www.mobihealthnews.com/news/telehealth-use-behavioral-health-increases-45x-pandemic-onset-and-more-digital-health-briefs</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">Telehealth use for behavioral health services has increased 45 times since the start of the COVID-19 pandemic across all care settings and provider types, </span><a href="https://www.trillianthealth.com/behavioral-health-trends-shaping-the-health-economy" target="_blank">according to a report by Trilliant Health</a>.</p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">Less than 1% of all behavioral health visits were delivered via telehealth pre-pandemic. By the second quarter last year, 32.8% of behavioral health appointments were conducted through telehealth. </span></p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">As of Q2 2022, behavioral health volumes were 18.1% above pre-pandemic levels. However, many people live in communities with relatively few behavioral healthcare providers. The average U.S. county has 81 providers for every 100,000 residents. </span></p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">Meanwh</span>ile, the report's authors note that 50.8% of residency positions are concentrated among six states (New York, California, Texas, Florida, Pennsylvania and Massachusetts).</p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">Private equity investments in the sector, including behavioral health virtual care and digital health platforms, have also declined, totaling $2.6 billion with 289 deals in 2022. That marks a 52.9% drop in funding and a 15.8% in deals compared with 2021.</span></p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">More Americans are taking medication to manage behavioral health conditions. Prescriptions increased by 58.2% among patients who took A</span>dderall and its generic to treat ADHD in individuals 22 to 44 years of age from Q1 2018 to Q2 2022. However, prescriptions of Adderall and its generic remained relatively unchanged in patients under 21 years old and over 45 years old.</p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">The report also found a 107.4% increase in eating disorder diagnoses among U.S. residents under the age of 18 and a 44% increase in depression disorders. Alcohol use was also on the rise during the pandemic, but 84% of patients seeking treatment for alcohol or substance use disorder who went to the emergency department did not receive follow-up care within 60 days. </span></p> <p dir="ltr"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">"Based on the principles of economics, if demand continues to exceed supply, prices will increase. This will inherently increase the economic burden facing the U.S. healthcare system, which is already fast approaching 20% of GDP," the report's authors wrote.</span></p> <hr /><p><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">AI-backed imaging and care coordination company </span><a href="https://www.mobihealthnews.com/tag/vizai" target="_blank">Viz.ai</a> signed a multi-year agreement with global pharmaceutical company <a href="https://www.mobihealthnews.com/tag/bristol-myers-squibb" target="_blank">Bristol Myers Squibb</a> to release an AI-enabled algorithm and software for provider workflow dubbed Viz HCM.</p> <p dir="ltr" style="margin-left:3.75pt;"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">Viz HCM will </span>help identify and assess patients for hypertrophic cardiomyopathy by reviewing routine electrocardiograms and identifying suspected cases for clinical review. It will be integrated into Viz.ai's Cardio Suite offering. </p> <p dir="ltr" style="margin-left:4pt;"><span id="docs-internal-guid-f82236d8-7fff-aae8-a0c7-d8074d23710f">The San Francisco-based company submitted a De Novo request to the FDA for the algorithm as a software-as-a-medical-device. </span></p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6322162997112" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> <p><em>Dr. Manish Kohli will offer more detail during his HIMSS23 session "Digital Bridges: Bringing Hope and Healing to Those Hurting Most." It is scheduled for Thursday, April 20, at 1-2 p.m. CT at the South Building, Level 4, in room S406 A.</em></p> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--20318.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--20318.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/digital-health">Digital Health</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Fri, 10 Mar 2023 17:41:12 +0000</pubDate> <dc:creator>JHagen</dc:creator> <guid isPermaLink="false">152816 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/telehealth-use-behavioral-health-increases-45x-pandemic-onset-and-more-digital-health-briefs#comments</comments> </item> <item> <title>Viz.ai partners with Us2.ai to integrate echocardiogram analysis tool</title> <link>https://www.mobihealthnews.com/news/vizai-partners-us2ai-integrate-echocardiogram-analysis-tool</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">AI-backed imaging and care coordination company </span><a href="https://www.mobihealthnews.com/tag/vizai" target="_blank">Viz.ai</a> announced a partnership with Us2.ai to utilize its echocardiogram analysis tool.</p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">This marks the second such partnership for the Singaporean startup, which last month announced it had </span><a href="https://www.mobihealthnews.com/news/aidoc-partners-us2ai-echocardiogram-analysis-tool" target="_blank">inked a deal</a> to integrate its algorithm into Aidoc's platform. </p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">Us2.ai's software looks for optimal images, takes measurements of the heart's structure and function, and then provides a report to clinicians. The algorithm received </span><a href="https://www.accessdata.fda.gov/cdrh_docs/pdf21/K210791.pdf" target="_blank">FDA 510(k) clearance</a> last year, and the company announced it had received a <a href="https://www.mobihealthnews.com/news/asia/singaporean-medtech-us2ai-gets-ce-mark-automated-cardiac-ultrasound-software" target="_blank">European CE mark</a> over the summer.</p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">As part of the collaboration, Viz.ai will offer Us2.ai’s software with the Viz Platform. It has received several FDA 510(k) clearances for its radiology software, including for </span><a href="https://www.mobihealthnews.com/news/vizai-receives-fda-clearance-pulmonary-embolism-related-algorithm" target="_blank">an algorithm</a> that could help determine the severity of a pulmonary embolism and a tool for flagging <a href="https://www.mobihealthnews.com/news/vizais-cerebral-aneurysms-algorithm-scores-fda-clearance" target="_blank">suspected cerebral aneurysms</a>.</p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">The company said the partnership will expand Viz.ai's cardiovascular offerings and decrease time from admission to treatment.</span></p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">"Echo is an essential tool in the delivery of cardiovascular care. We believe that no heart disease patient should have to wait for care when time is critical," Chris Mansi, CEO of Viz.ai, said in a statement. </span></p> <p><span>"The average time to complete an echo takes </span><a href="https://my.clevelandclinic.org/health/diagnostics/16947-echocardiogram#" target="_blank">up to 60 minutes</a>, plus additional reporting time. Using AI can dramatically reduce this time burden, as well as ensure a uniform standard of excellence in reporting. We are proud to partner with Us2.ai to enhance and complement our comprehensive AI platform, tailoring it to cardiovascular needs, so that cardiologists and care teams can provide optimal care to more patients most efficiently."</p> <p><strong><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">THE LARGER TREND</span></strong></p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">Us2.ai, which used to be known as Eko.ai, launched in 2017 and raised </span><a href="https://us2.ai/us2-ai-secures-us15m-series-a-to-improve-detection-of-cardiovascular-disease/" target="_blank">$15 million in Series A funding</a> earlier this year. </p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">Viz.ai announced a </span><a href="https://www.mobihealthnews.com/news/stroke-care-coordination-company-vizai-lands-100m" target="_blank">$100 million Series D round</a> in April, boosting its valuation to $1.2 billion. That round came about a year after its <a href="https://www.mobihealthnews.com/news/vizai-raises-71-million-expand-beyond-stroke-care-coordination" target="_blank">$71 million Series C raise</a>. </p> <p><span id="docs-internal-guid-f1f82d14-7fff-c4f8-97a6-483c0a50e573">According to the </span><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm" target="_blank">FDA's database</a>, the company has received seven 510(k) clearances, with four receiving a decision this year.</p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6314690257112" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--19907.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--19907.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/ai-data-and-analytics">AI</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Wed, 02 Nov 2022 20:34:14 +0000</pubDate> <dc:creator>EmilyOlsen</dc:creator> <guid isPermaLink="false">152405 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/vizai-partners-us2ai-integrate-echocardiogram-analysis-tool#comments</comments> </item> <item> <title>Viz.ai receives FDA clearance for pulmonary embolism-related algorithm</title> <link>https://www.mobihealthnews.com/news/vizai-receives-fda-clearance-pulmonary-embolism-related-algorithm</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">AI-backed imaging and care coordination company </span><a href="https://www.mobihealthnews.com/tag/vizai" target="_blank">Viz.ai</a> received FDA 510(k) clearance for an algorithm that could help determine the severity of a pulmonary embolism. </p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">The startup received the agency's green light </span><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K221100" target="_blank">late last month</a> for its RV/LV ratio algorithm, which measures the diameter of the ventricles of the heart to provide the ratio of the maximum right ventricle diameter compared with the left ventricle. Determining the ratio could<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705138/" target="_blank"> help identify right ventricular dysfunction in the heart</a>, which can be a sign of poor outcomes. </p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">"With this clearance, the Viz PE Solution now includes both detection of clot in the lungs and degree of strain on the right heart," Dr. Kenneth Rosenfield, section head of vascular medicine and intervention at Massachusetts General Hospital and cofounder of the PERT Consortium, said in a statement. Viz.ai is a sponsor of the PERT Consortium, which focuses on research and care for pulmonary embolism.</span></p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">"This will enable clinicians to quickly triage patients and treat them appropriately, by providing a powerful tool for early detection and risk stratification. This expedited critical decision-making will undoubtedly save lives."</span></p> <p><strong><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">THE LARGER TREND</span></strong></p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">This clearance marks Viz.ai's third 510(k) so far this year. In late July, it announced Viz Subdural had been cleared to </span><a href="https://www.viz.ai/press-release/viz-ai-receives-fda-510-k-clearance-for-viz-subdural-sdh" target="_blank">flag potential cases of subdural hemorrhage</a>. It also received a 510(k) in February for an algorithm <a href="https://www.mobihealthnews.com/news/vizais-cerebral-aneurysms-algorithm-scores-fda-clearance" target="_blank">designed to detect cerebral aneurysms</a>. </p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">Viz.ai most recently </span><a href="https://www.mobihealthnews.com/news/stroke-care-coordination-company-vizai-lands-100m" target="_blank">raised a $100 million Series D round</a> that boosted its valuation to $1.2 billion. When the round was announced in April, the company said it would use the capital to fuel growth and add new triaging capabilities to its platform. Founded in 2016, Viz.ai has scooped up more than $250 million in venture dollars.</p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">There are a number of companies focused on using AI to detect and triage potential health concerns based on imaging results. Earlier this summer, Aidoc </span><a href="https://www.mobihealthnews.com/news/aidoc-raises-110m-expand-ai-enabled-imaging-platform" target="_blank">raised $110 million in a Series D funding round</a> to continue expanding its platform, which includes its AI tools and care-coordination software. It recently received FDA 510(k) clearances for tools to find and triage potential <a href="https://www.mobihealthnews.com/news/aidoc-software-receives-fda-green-light-flagging-triaging-brain-aneurysms" target="_blank">brain aneurysms</a> and <a href="https://www.mobihealthnews.com/news/fda-clears-aidoc-ai-powered-pneumothorax-detection-tool" target="_blank">pneumothorax</a>, or a collapsed lung.</p> <p><span id="docs-internal-guid-995656c4-7fff-b19d-d5ea-c429dbf1c2b2">In May, RapidAI </span><a href="https://www.mobihealthnews.com/news/rapidai-receives-fda-510k-identify-potential-pulmonary-embolism" target="_blank">received clearance</a> for its own pulmonary embolism-focused tool. Other companies in the AI imaging space include <a href="https://www.mobihealthnews.com/news/gleamer-scores-fda-510k-ai-enabled-fracture-detection" target="_blank">Gleamer</a>, <a href="https://www.mobihealthnews.com/news/digital-x-ray-company-nanox-wraps-merger-zebra-medical-vision" target="_blank">Nanox</a> and <a href="https://www.mobihealthnews.com/news/qureai-gets-fda-greenlight-ai-algorithm-breathing-tube-placement-and-other-digital-health" target="_blank">Qure.ai</a>.</p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6311022039112" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--19718.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--19718.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/regulation">Regulation</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Tue, 06 Sep 2022 17:18:51 +0000</pubDate> <dc:creator>EmilyOlsen</dc:creator> <guid isPermaLink="false">152216 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/vizai-receives-fda-clearance-pulmonary-embolism-related-algorithm#comments</comments> </item> <item> <title>Stroke care coordination company Viz.ai lands $100M </title> <link>https://www.mobihealthnews.com/news/stroke-care-coordination-company-vizai-lands-100m</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">Artificial intelligence-backed health-tech startup Viz.ai announced a $100 million Series D funding round that brings its total valuation to $1.2 billion. Tiger Global and Insight Partners led the round, with participation from Scale Ventures, Kleiner Perkins, Threshold, GV, Sozo Ventures, CRV and Susa. </span></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">This news comes roughly a year after the company closed its</span><a href="https://www.mobihealthnews.com/news/vizai-raises-71-million-expand-beyond-stroke-care-coordination" target="_blank"> $71 million Series C round</a>. As of today, the company has more than $250 million in venture investment. </p> <p dir="ltr"><strong><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">WHAT IT DOES</span></strong></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">Viz.ai built a care-coordination tool designed to help clinical teams share images and detect potential diseases. The product's AI tool is able to help triage the clinical images and detect strokes, and in turn help care teams prioritize patients. Currently its offering includes AI detection productions for aortic diseases, pulmonary embolism and cerebral aneurysms. The company noted that it has a pending 510(k) clearance for subdural hematoma. </span></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">Specialists using the system are able to access a mobile view of scans, which allows them to zoom in and out of images and visualize the scan in 3D.</span></p> <p dir="ltr"><strong><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">WHAT IT'S FOR </span></strong></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">The company said the new funds will help fuel growth in the company. The money will also go towards adding new disease-triaging capabilities to the Viz Platform. </span></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">"We will continue to invest heavily in cutting-edge technology and services to integrate deeply into the clinical workflow, allowing us to automate disease detection, increase diagnostic rates and enhance workflows across the entire hub and spoke health system," Dr. Chris Mansi, Viz.ai cofounder and CEO, said in a statement. </span></p> <p dir="ltr"><span>"More patients receive the right treatment, resulting in better patient outcomes and improved financial efficiency for the health system."</span></p> <p><strong><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">MARKET SNAPSHOT </span></strong></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">Founded in 2016, the company landed an </span><a href="https://www.mobihealthnews.com/content/vizai%E2%80%99s-stroke-detecting-cds-app-receives-fda-nod" target="_blank">FDA De Novo in 2018 </a>for its Viz.ai Contact, a clinical decision-support tool that analyzes CT scans and flags a detected stroke. The startup has continued to work with the FDA on new algorithms. Most recently, in February the company landed an FDA <a href="https://www.mobihealthnews.com/news/vizais-cerebral-aneurysms-algorithm-scores-fda-clearance" target="_blank">510(k) clearance for its algorithm designed to detect cerebral aneurysms</a>. </p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">There are several digital health companies working in the stroke-care space. For example, in 2021 Indian startup </span><a href="https://www.mobihealthnews.com/news/asia/qureai-rolls-out-ai-stroke-management-platform" target="_blank">Qure.ai </a>announced a new stroke management platform that lets providers remotely diagnose and make decisions. Additionally, stroke-triaging company MindRhythm launched a multicenter clinical trial to test the effectiveness of its stroke-detecting technology also in 2021. </p> <p dir="ltr"><strong><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">ON THE RECORD </span></strong></p> <p dir="ltr"><span id="docs-internal-guid-f095b15a-7fff-7a8b-eabd-b4e08d9cd060">"Viz.ai is the standout AI healthcare company; they are first-in-class in intelligent care coordination, with a solid foundation of clinical evidence supporting the value delivered to healthcare providers and patients," John Curtius, partner at Tiger Global, said in a statement. "We see meaningful upside as the company expands to help life science companies expedite clinical trials and accelerate patient access to new effective treatments."</span></p> <p> </p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6302858167001" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--19231.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--19231.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/finance">Finance</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Thu, 07 Apr 2022 17:35:50 +0000</pubDate> <dc:creator>laura.lovett@himssmedia.com</dc:creator> <guid isPermaLink="false">151729 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/stroke-care-coordination-company-vizai-lands-100m#comments</comments> </item> <item> <title>Viz.ai's cerebral aneurysms algorithm scores FDA clearance </title> <link>https://www.mobihealthnews.com/news/vizais-cerebral-aneurysms-algorithm-scores-fda-clearance</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">Artificial intelligence care coordination company Viz.ai landed an FDA 510(k) clearance for its new algorithm designed to detect cerebral aneurysms. Dubbed Viz Aneurysm, the technology was designed to pinpoint the condition from CT scans.</span></p> <p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">The new algorithm will fit into Viz Intelligent Care Coordination Platform, and be used to help streamline getting detected aneurysm into the clinical workflow. In a pilot study, conducted by the </span><a href="https://www.ahajournals.org/doi/10.1161/str.51.suppl_1.141" target="_blank">University of Toronto</a>, "data analysis demonstrated 94% accuracy of the algorithm", according to a press statement. </p> <p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">"The Viz.ai aneurysm algorithm was able to detect cerebral aneurysms in consecutive CTAs. The model has demonstrated that a deep learning AI algorithm can achieve clinically useful levels of accuracy for clinical decision support and will help us to improve how we help aneurysm patients,” Dr. Vitor Mendes Pereira, director of Endovascular Research and Innovation, University of Toronto, said in a statement. </span></p> <p dir="ltr"><strong><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">WHY IT MATTERS </span></strong></p> <p><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237"><a href="https://www.bafound.org/about-brain-aneurysms/brain-aneurysm-basics/brain-aneurysm-statistics-and-facts/" target="_blank">According to the Brain Aneurysm Foundation</a></span>, 6.5 million people in the U.S. have an unruptured brain aneurysm. Each year about 30,000 patients in the U.S. have a brain aneurysm rupture. </p> <p><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">Viz.ai is pitching its new algorithm as a way to help catch cerebral aneurysms earlier on. </span></p> <p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">“Viz ANEURYSM has the potential to significantly increase the number of aneurysms detected and clinically followed,” Jayme Strauss, chief clinical officer, Viz.ai, said in a statement. “The combination of detection with an ability to schedule patients for neurovascular specialist follow-up is an important advancement for aneurysm patients, helping patients obtain the necessary follow-up from this potentially deadly disease and driving improved outcomes on the population health level.”</span></p> <p><strong><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">THE LARGER TREND </span></strong></p> <p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">In March of 2021 </span><a href="https://www.mobihealthnews.com/news/vizai-raises-71-million-expand-beyond-stroke-care-coordination" target="_blank">Viz.ai scored $71 million in Series C funding</a>, bringing its total funding raise to $150 million. The company landed an <a href="https://www.mobihealthnews.com/content/vizai%E2%80%99s-stroke-detecting-cds-app-receives-fda-nod" target="_blank">FDA De Novo in 2018 for its Viz.ai </a>Contact, a clinical decision-support tool that analyzes CT scans and flags a detected stroke. </p> <p dir="ltr"><span id="docs-internal-guid-35d6c339-7fff-f592-75ee-e1b113fd6237">Viz.ai isn't the only digital health company working on stroke care. </span><a href="https://www.mobihealthnews.com/news/mindrhythm-launches-multicenter-clinical-trial-research-stroke-triage" target="_blank">MindRhythms</a>, a stroke-triage company, launched its multicenter clinical trial research in April of 2021. Additionally <a href="https://www.mobihealthnews.com/news/sharecares-spac-confirmed-brainqs-breakthrough-device-designation-and-more-digital-health-news" target="_blank">BrainQ</a>, a company that uses AI to deliver electromagnetic field therapy to stroke patients through a wearable, landed an FDA Breakthrough Device Designation in 2021. </p> <div> </div> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6296159054001" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--19052.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--19052.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/regulation">Regulation</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Thu, 24 Feb 2022 18:36:54 +0000</pubDate> <dc:creator>laura.lovett@himssmedia.com</dc:creator> <guid isPermaLink="false">151550 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/vizais-cerebral-aneurysms-algorithm-scores-fda-clearance#comments</comments> </item> <item> <title>Roundup: Philips announces new chief innovation and strategy officer, robotics to improve adult social care and more briefs </title> <link>https://www.mobihealthnews.com/news/emea/roundup-philips-announces-new-chief-innovation-and-strategy-officer-robotics-improve-adult</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p><strong>ROBOTS FOR ADULT SOCIAL CARE </strong></p> <p>As part of the Social Care Digital Innovation Programme and the Social Care Digital Innovation Accelerators projects, 69 local authorities have developed and showcased robotic digital approaches to assist in adult social care.</p> <p>Run by NHS Digital in collaboration with the Local Government Association, the computer-controlled robots – known as ‘cobots’ – were trialled in the Isle of Wight and Hampshire.</p> <p>The robotic devices are worn around the waist and lower back to support carers in lifting, holding and moving people without assistance. </p> <p>The cobots aim to lessen the risk of injury and fatigue among carers and reduce the need for two carers to work together.</p> <hr /><p><strong>PHILIPS ANNOUNCES NEW CHIEF INNOVATION AND STRATEGY OFFICER</strong></p> <p>Shez Partovi has officially taken on the role of chief innovation and strategy officer at Philips, succeeding Jeroen Tas and reporting to Philips CEO, Frans van Houten.</p> <p>Partovi brings his background as a clinician to the role, having trained as a physician at McGill University in Montreal and practised as a neuroradiologist for a decade.</p> <p>He also encompasses entrepreneurial expertise and consumer knowledge, having previously taken on the role of chief digital officer for a large health system.</p> <p>"One of the most exciting trends I’m seeing that's driving innovation in healthcare is an increasing focus on the experience. As individuals, we are at a point where our best experience anywhere is what we expect everywhere, and that means there’s a huge opportunity to innovate how we receive healthcare so the experience is superior," said Partovi.</p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6253073626001" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> <hr /><p><strong>VIZ.AI EXPANDS TO EUROPE WITH CE MARK </strong></p> <p>San Francisco-based Viz.ai has been awarded a CE Mark for its AI-powered stroke care software, establishing its adherence with European health, safety and environmental protection standards for products sold within the European Economic area.</p> <p>Through its software suite, Viz.ai's system synchronises stroke care by connecting multidisciplinary care teams, coordinating care and decreasing time to treatment. </p> <p>In the EU, stroke is the second most common cause of death and a leading cause of adult disability, but only an estimated 1.9 percent receive an endovascular procedure that removes blood clots.</p> <p>“Minutes matter when you’re having a stroke, which is why Viz.ai is dedicated to reducing time to treatment and improving patient outcomes through improved care coordination,” said Chris Mansi, co-founder and CEO of Viz.ai. “The CE Mark allows us to bring our leading AI software to the EU, significantly expanding the number of patients we can help get access to life saving therapy.”</p> <hr /><p><strong>PALANTIR APPOINTS NEW UK MANAGING DIRECTOR </strong></p> <p>US-based software company Palantir Technologies has announced that it is bolstering its UK global health and life sciences capability with the appointment of a new managing director.</p> <p>Dr Justin Whatling joins Palantir from Cerner and will work with a number of Palantir’s foundry clients, including NHS England and hospital trusts across the UK to help maximise the potential of Palantir’s software.</p> <p>Dr Whatling told <em>MobiHealthNews</em>: “I am looking forward to steering Palantir’s health practice at a time when the need to support health systems has never been more apparent.</p> <p>“I know from my previous roles how powerful data can be when utilised correctly and have witnessed first-hand how it can help streamline our health system’s infrastructure. I truly believe Palantir’s software that integrates data [in near real time] at enterprise level will provide a real boost to optimising care delivery at a time when we need this most to support COVID catchup and to support Integrated Care Systems establish and operate new care models up and down the country.”</p> <hr /><p><strong>LEVA CLINIC PARTNERS WITH BOOTS </strong></p> <p>London-based Leva Clinic, an online clinic specialising in chronic pain, has partnered with Boots UK &amp; Ireland to expand its suite of digital pain services.</p> <p>From today, Leva Clinic will become part of the Boots Health Hub, alongside other healthcare partners.</p> <p>Leva Clinic’s in-house healthcare professionals have condensed expertise into a personal pain management programme, in the form of a web-based app. As part of the agreements, users will be able to purchase the pain management programme from Boots Health Hub, a marketplace that serves as a gateway to Boots and third party online healthcare services.</p> <p>Programme topics include understanding pain, communicating about your pain, work, relationships, movement and medications. During the programme, patients have access to daily mindfulness practices from the clinical psychologist team, and instant chat with Leva Clinic’s health coach team.</p> <p>Eric Bystrom, CEO at Leva Clinic, said: “The digital pain management programme has been designed by our multidisciplinary team of leading pain doctors, nurses, clinical psychologists, physiotherapists and people living with pain. We have created a best in class pain management app which is easily accessible online. We are very excited to partner with Boots to expand our distribution of the programme to patients throughout the UK as we believe that the better you understand your pain, the better you can manage it.” </p> <p> </p> <p> </p> <p> </p> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--17771.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--17771.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/emerging-technologies">Emerging Technologies</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Fri, 02 Jul 2021 10:47:45 +0000</pubDate> <dc:creator>SaraMageit</dc:creator> <guid isPermaLink="false">150268 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/emea/roundup-philips-announces-new-chief-innovation-and-strategy-officer-robotics-improve-adult#comments</comments> </item> <item> <title>Viz.ai raises $71 million to expand beyond stroke care coordination</title> <link>https://www.mobihealthnews.com/news/vizai-raises-71-million-expand-beyond-stroke-care-coordination</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p>Today Viz.ai, an artificial intelligence care coordination company, shared the closing of its Series C funding round worth $71 million.</p> <p>Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures.</p> <p>This latest round comes about a year and a half after its <a href="https://www.mobihealthnews.com/news/stroke-focused-health-ai-company-vizai-lands-50m" target="_blank">$50 million Series B raise</a>. To date, Viz.ai has raised $150 million.</p> <p><strong>WHAT IT DOES</strong></p> <p>The Viz.ai platform harnesses AI to automatically review CT scans and search for suspected large vessel occlusions, a common type of stroke. Once identified, the platform alerts all members of the stroke team to triage the patient.</p> <p>In clinical studies, the Viz LVO system could identify and notify care teams of suspected strokes in under six minutes, allowing for faster treatment and better patient outcomes, Viz.ai said.</p> <p>The company also has tools for sharing patient information before the CT scan takes place, offering patient referrals, viewing scans on mobile devices, as well as a HIPAA-compliant communication platform for clinical care coordination.</p> <p><strong>WHAT ITS FOR</strong></p> <p>With this raise, Viz.ai plans to broaden its AI care coordination tool to support other areas of acute care, such as cardiology, pulmonary and trauma. It also aims to grow into new global markets.</p> <p>“This latest round of funding validates the potential of Viz.ai’s technology, both in and beyond stroke care coordination,” Chris Mansi, cofounder and CEO of Viz.ai, said in a statement.</p> <p>“The investment will allow us to expedite our effort to bring the power of artificial intelligence and advanced mobile technology to prevent care breakdowns, improve patient outcomes and experience, and improve economics across the entire health system, both in the United States and Europe.”</p> <p><strong>MARKET SNAPSHOT</strong></p> <p>The company’s stroke-detecting clinical decision-support tool received <a href="https://www.mobihealthnews.com/content/vizai%E2%80%99s-stroke-detecting-cds-app-receives-fda-nod" target="_blank">de novo 510(k) clearance</a> in 2018, and since then the company has worked to expand its reach through new workflows and partnerships. Viz.ai <a href="https://www.mobihealthnews.com/news/vizai-medtronic-team-bring-stroke-tech-more-centers-fda-extends-partnership-dassault-syst-mes" target="_blank">teamed up with Medtronic</a> in 2019 to speed up the adoption of the Viz LVO platform into more stroke-treatment centers in the U.S.</p> <p>The AI stroke software also <a href="https://www.mobihealthnews.com/news/mobile-platform-helps-collect-family-health-histories-digital-cbt-improves-eating-disorder" target="_blank">landed a New Technology Add-on Payment (NTAP) designation </a>from the Centers for Medicare and Medicaid Services last year, which gives it an add-on payment of $1,040 per use in treating a patient with a stroke or suspected stroke.</p> <p>AI clinical decision-support technologies have <a href="https://www.mobihealthnews.com/news/emea/future-medical-technology-devices-time-covid-19" target="_blank">taken off</a> over the last year, in part due to the pandemic.</p> <p>Also in the stroke imaging space is RapidAI, which recently <a href="https://www.mobihealthnews.com/news/rapidai-snags-fda-clearance-neuroimaging-analysis-device" target="_blank">received clearance</a> from the FDA for its Rapid ASPECTS neuroimaging analysis device.</p> <p>Outside of strokes, this kind of tech is being used to <a href="https://www.mobihealthnews.com/news/etiometry-adds-more-clinical-decision-support-tools-its-platform-510k-clearance" target="_blank">monitor patient risks in intensive care units</a>, to <a href="https://www.mobihealthnews.com/news/ibex-medical-analytics-draws-38m-series-b-expand-its-ai-pathology-platforms" target="_blank">support cancer diagnostics</a> and to <a href="https://www.mobihealthnews.com/news/cds-algorithm-predicts-covid-19-complications-receives-emergency-use-authorization-fda" target="_blank">predict COVID-19 complications</a>.</p> <p> </p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" src="https://players.brightcove.net/1824526989001/default_default/index.html?videoId=6238968797001" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;"></iframe></div> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--17201.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--17201.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <div class="field field-name-enterprise-taxonomy-primary-topic field-type-ds field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field field-name-enterprise-taxonomy-topic field-type-entityreference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/topics/investing">Investing</a></div></div></div></div></div></div> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Wed, 17 Mar 2021 15:54:37 +0000</pubDate> <dc:creator>MalloryHackett</dc:creator> <guid isPermaLink="false">149697 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/vizai-raises-71-million-expand-beyond-stroke-care-coordination#comments</comments> </item> <item> <title>Stroke-focused health AI company Viz.ai lands $50M </title> <link>https://www.mobihealthnews.com/news/stroke-focused-health-ai-company-vizai-lands-50m</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p>Healthcare AI company Viz.ai announced that it landed a whopping $50 million in Series B funding this morning. This latest infusion of cash was led by Greenoaks, with participation from Threshold Ventures, CRV, GV and Kleiner Perkins. </p> <p>The new funding comes a little over a year after the Israeli company raised <strong><a href="https://www.mobihealthnews.com/content/vizai-secures-21m-kleiner-perkins-google">$21 million from Kleiner Perkins and GV</a></strong>. </p> <p><strong>WHAT THEY DO </strong></p> <p>Viz.ai focuses on using AI to triage stroke patients and coordinate care. Specifically, using a deep learning algorithm the technology aims to highlight suspected large vessel occlusion. The system then alerts all members of the stroke team. Clinicians can tap into a smartphone interface to view images and insights. Part of the company’s goal is to synchronize stroke care. </p> <p><strong>WHAT IT’S FOR </strong></p> <p>The new money will be put towards expanding the technology to more locations. </p> <p>“Viz.ai’s mission is to improve access to lifesaving treatments. In stroke, by saving time for the hospital system, we can achieve significant cost savings for the payer and most importantly, improved outcomes for the patient. This round of funding will enable us to expand the benefits of Synchronized Care to more disease states and geographies, democratizing the quality of health care globally,” Chris Mansi, CEO of Viz.ai, said in a statement.</p> <p><strong>MARKET SNAPSHOT</strong></p> <p>Viz.ai received <a href="https://www.mobihealthnews.com/content/vizai%E2%80%99s-stroke-detecting-cds-app-receives-fda-nod"><strong>de novo 510(k) clearance for Contact</strong></a>, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke, in 2018. Since then the company has inked a number of deals with major players in the field. In July the company announced it was joining forces with Medtronic. The partnership is revolved around getting <strong><a href="https://www.mobihealthnews.com/news/vizai-medtronic-team-bring-stroke-tech-more-centers-fda-extends-partnership-dassault-syst-mes">Viz.ai’s system</a> </strong>into more treatment centers in the US. It has also struck a deal with <strong><a href="https://www.mobihealthnews.com/content/webmd-now-available-china-sanofi-and-nutrino-team-and-more-digital-health-deals">Tennessee-based Erlanger Health System</a> </strong>to deploy its Viz LVO system in the hospitals. </p> <p>While stroke care has been a popular topic in digital health, the bulk of the focus is on rehabilitation. For example, the <strong><a href="https://www.mobihealthnews.com/content/kessler-foundation-virtualware-team-create-vr-tool-stroke-patients">Kessler Foundation and Virtualware</a> </strong>teamed up in 2018 on a new virtual reality tool aimed at helping stroke patients recover. Additionally, <strong><a href="https://www.mobihealthnews.com/content/wearable-sensor-patches-throat-unplug-stroke-rehabilitation">Northwestern University engineers</a> </strong>developed sensor patches to better monitor stroke patients during home recovery. </p> <p><strong>ON THE RECORD </strong></p> <p>“We see Viz.ai as the future of how healthcare is delivered. With rising costs and more focus on value-based care, there needs to be an emphasis on delivering the highest quality care in the shortest amount of time while reducing costs,” Neil Shah of Greenoaks said in a statement.</p> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--14223.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--14223.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Thu, 24 Oct 2019 19:28:22 +0000</pubDate> <dc:creator>laura.lovett@himssmedia.com</dc:creator> <guid isPermaLink="false">147131 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/stroke-focused-health-ai-company-vizai-lands-50m#comments</comments> </item> <item> <title>Viz.ai, Medtronic team up to bring stroke tech to more centers, FDA extends partnership with Dassault Systèmes and more digital health deals</title> <link>https://www.mobihealthnews.com/news/vizai-medtronic-team-bring-stroke-tech-more-centers-fda-extends-partnership-dassault-syst-mes</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p>Healthcare artificial intelligence company <strong>Viz.ai </strong>announced that it is joining forces with <strong>Medtronic </strong>with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US. </p> <p>“Medtronic is an innovative company focused on therapies that extend life and restore health,” Dr. Chris Mansi, cofounder and CEO of Viz.ai, said in a statement. “As the largest medical device company in the world, Medtronic is an ideal partner to help physicians access Viz.ai’s cutting-edge technology to ensure as many patients get the care they need as quickly as possible.” </p> <p>…</p> <p>The <strong>FDA </strong>has inked a deal with French company <strong>Dassault Systèmes </strong>extending its ongoing partnership to develop a platform, called 3DEXPERIENCE, aimed at facilitating a more efficient review of cardiovascular and medical devices. The announcement means that the two will continue the relationship for another five years, entering into the second phase of the collaboration which will use virtual patients “based on computational modeling and simulation to improve efficiency of clinical trials for new device designs.”</p> <p>“Our collaboration with the FDA underscores the relevance and sustainability of digital twin experiences created with the 3DEXPERIENCE platform to test devices and drugs in scientific and medical innovation,” Claire Biot, VP of life sciences industry at Dassault Systèmes, said in a statement. “Enriching technology already well established in regulated industries such as aerospace and automotive, virtual patients support the complex development of therapies for the heart, brain and more by eliminating traditional cost and time bottlenecks. With this new review process, Dassault Systèmes and the FDA can be partners in the transformative impact of the virtual world on industrial innovation, new treatments and the patient experience.”</p> <p>…</p> <p>This morning health coaching platform <strong>Liva Healthcare </strong>struck a new deal with NHS-funded <strong>Care City</strong>, a program dedicated to using innovation to improve healthy aging. As part of the deal NHS doctors will work with the platform to create a nine-month behavioral change program for folks living with Type 2 diabetes. As part of the program, patients will get a personal coach who they can chat with over video. The app will also help them keep track of their progress. </p> <p>“Patients want to take a more active role in managing their own health,” John Craig, chief executive of Care City, said in a statement. “Our partnership with Liva Healthcare responds well to exactly this need and we are excited to see what positive, long-term outcomes flourish from this collaboration.”</p> <p>…</p> <p>On Tuesday <strong>SnapMD</strong>, a telemedicine company that specializes in the enterprise market, announced a partnership with healthcare-focused plug-and-play platform <strong>Carefluence </strong>to develop a new enterprise telemedicine platform. Dubbed Virtual Care Management, the new system will integrate with the EHR software ModuleMD.</p> <p>“SnapMD and Carefluence’s partnership helps to remove the barriers of technology differences that hinder collaboration and to virtually connect the care continuum,” Dave Skibinski, president and CEO of SnapMD, said in a statement. “Our telemedicine software will now provide Carefluence customers with a true point-of-care solution for virtual care interactions.”</p> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--13914.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--13914.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Thu, 25 Jul 2019 19:58:26 +0000</pubDate> <dc:creator>laura.lovett@himssmedia.com</dc:creator> <guid isPermaLink="false">146712 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/news/vizai-medtronic-team-bring-stroke-tech-more-centers-fda-extends-partnership-dassault-syst-mes#comments</comments> </item> <item> <title>Roundup: 12 healthcare algorithms cleared by the FDA</title> <link>https://www.mobihealthnews.com/content/roundup-12-healthcare-algorithms-cleared-fda</link> <description><div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even" property="content:encoded"><p>Every day sees strides across the field of artificial intelligence, and healthcare is just one of the many industries looking to smart automation as a means to reduce burden and improve results. The last year in particular has brought a wealth of new healthcare focused software tools to the forefront, and as such has <a href="https://www.mobihealthnews.com/content/fda-reneged-its-promise-take-risk-based-approach-cds-software"><strong>ignited debate</strong></a> on how these algorithms are being reviewed and regulated by the FDA.</p> <p>“FDA is lagging in the production of guidance to explain its approach for these newer products. This is a problem, because Commissioner Gottlieb himself in a blog post noted well over a year ago that individual decision-making by FDA is not enough for digital therapeutics to thrive,” Bradley Merrill Thompson, a lawyer at Epstein Becker &amp; Green who also leads CDS Coalition, an industry group, wrote in an email on the subject.</p> <p>“Industry has been asking since 2015 for better guidance on the use of software-based algorithms in connection with drug administration. The commissioner, starting in April 2018, has been promising new guidance focused on the use of software with drugs, and in fact reiterated that promise only a couple weeks ago. But the concern is that the new guidance may not be focused on the issues of greatest concern to industry. We shall have to wait to see.”</p> <p>Thompson also noted that while the agency is relying on its 510(k) regulatory pathways in the meantime, the heterogeneity of these nontraditional tools has resulted in an ever-growing number of De Novo clearances and device classifications. Below, MobiHealthNews has collection of 12 algorithm clearances — five De Novo, seven 510(k) — spanning the breadth of digital health.<br /> </p> <hr /><p> <strong>Viz.ai</strong>’s Contact is a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke. <a href="https://mobihealthnews.com"><strong>Approved through the agency’s De Novo premarket review pathway</strong></a>, the software uses an AI algorithm to scan CT images for indicators associated with stroke, and then sends a text notification to a neurovascular specialist if it identifies a potential large vessel blockage. Because the tool alerts the specialist during the time a first-line provider is reviewing the images, patients may receive attention from a specialist earlier than they would normally. Contact is not intended to be a stand in for a full patient evaluation when diagnosing a case.</p> <p><strong>IDx</strong>’s IDx-DR is an AI software system for the autonomous detection of diabetic retinopathy in adults who have diabetes. The algorithm analyzes images taken with the Topcon NW400 retinal camera and uploaded to a cloud server. Within minutes the software provides doctors with a binary result, either indicating that more than mild diabetic retinopathy is present and that the patient should be referred to an eye care professional, or that the screen is negative and should be repeated in 12 months. <a href="https://www.mobihealthnews.com/content/fda-permits-marketing-ai-software-autonomously-detects-diabetic-retinopathy"><strong>Approved in April</strong></a>, the software is notable in that it was the first AI-based diagnostic system to be authorized by the FDA for commercialization in the US that can provide a screening decision without the need for clinician interpretation.</p> <p><strong>MaxQ AI</strong>’s Accipio Ix in an AI workflow tool designed to help clinicians prioritize adults patients likely presenting with acute intracranial hemorrhage. <a href="https://www.mobihealthnews.com/content/maxq-ai-wins-fda-510k-clearance-acute-intracranial-hemorrhage-triage-algorithm"><strong>Cleared just last week</strong></a>, the algorithm automatically retrieves and processes non-contrast CT images to provide a case-level indicator, which is used to triage cases most in need of expert review and diagnosis. MaxQ AI CEO and Chairman Gene Saragnese noted in an announcement that it is the first in a planned wider ecosystem of similar apps.</p> <p><strong>Imagen</strong>’s OsteoDetect uses an AI algorithm to scan X-ray images for a common type of wrist bone fracture, known as distal radius fracture. The software can be fed images of adult wrists in the posterior-anterior and medial-lateral position, and using these highlights regions with potential fracture. OsteoDetect — which <a href="https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm608833.htm"><strong>received De Novo clearance in May</strong></a> — is intended for use by primary, emergency, urgent and specialty care practitioners alike, but should be accompanied by a standard clinical review.</p> <div class="alert alert-warning" role="alert"><a href="https://www.himsslearn.org/how-ai-will-revolutionize-precision-medicine?source=Mobistory" target="_blank"><strong>Webinar: </strong>How AI Will Revolutionize Precision Medicine</a></div> <p> The cloud-based <strong>DreaMed </strong>Advisor Pro is a diabetes treatment decision support product that analyzes data from continuous glucose monitors, insulin pumps and self-monitoring to determine an insulin delivery recommendation. Through an event-based learning process, the software incorporates a number of components into its recommendations, including basal rate, carbohydrate ratio and correction factor. Dosage recommendations are delivered directly to the monitoring clinician, who can push the adjustment to a patient’s diabetes management devices with the click of a button. <a href="https://www.mobihealthnews.com/content/fda-grants-dreameds-de-novo-request-device-friendly-diabetes-software"><strong>FDA granted DreaMed’s algorithm a De Novo approval</strong></a> in June.</p> <p><strong>AliveCor</strong> received 510(k) clearance back in 2014 for <a href="https://www.mobihealthnews.com/36859/alivecor-launches-new-app-with-fda-cleared-afib-algorithm/"><strong>the AF algorithm</strong></a>, an app-based algorithm that workers with the company’s smartphone ECG device to detect atrial fibrillation. Being a consumer-focused tool, users who receive a positive result are encouraged to print out confirm their results with a board-certified cardiologist.</p> <p>Less than a year later, AliveCor also received <a href="https://www.mobihealthnews.com/40089/alivecor-ecg-gets-fda-clearance-for-two-more-algorithms"><strong>clearance for two more related algorithms</strong></a>: the Normal Detector, which assures patients that their personal ECG is free of abnormalities; and the Interference Detector, a tool that automatically detects whether interference could be compromising their ECG test.</p> <p>On the subject of atrial fibrillation, <strong>Apple</strong> made waves a few months back when it announced that its latest ECG-equipped smartwatch would also come with <a href="https://www.mobihealthnews.com/content/apple-watch-series-4-will-have-fda-cleared-ecg-fall-detection"><strong>an algorithm to detect irregular heart rates</strong></a>. The software, which required the consumer tech company to seek a De Novo marketing approval, can monitor the user’s heart rate behind its various other functions, and alerts the wearer when it notices cause for concern.</p> <p><strong>Bay Labs</strong>’ <a href="https://www.businesswire.com/news/home/20180619005552/en/Bay-Labs%E2%80%99-EchoMD-AutoEF-Software-Receives-FDA"><strong>EchoMD AutoEF software</strong></a> assists cardiologists by using an algorithm to automatically review relevant digital video clips collected from an echocardiography study, rates their quality and then selects the best to calculate ejection fraction, a key measure of cardiac function. Of note, the software can be integrated into a cardiologist’s routine diagnostic workflow to better assist decision making.</p> <p>The Coronary Calcium Scoring algorithm from <strong>Zebra Medical Vision</strong> offers a coronary artery calcification score from a patient’s ECG-gated CT scan. Clinicians can use this score to flag patients at high risk of cardiovascular disease sooner, thereby allowing for quicker and more effective care. The <a href="https://www.mobihealthnews.com/content/zebra-medical-vision-receives-its-first-510k-clearance-coronary-artery-calcification"><strong>July 510(k) clearance</strong></a> was the first for the Israel-based company, which also holds a number of algorithm clearances in the EU.</p> <p>In February, medical imaging software company <strong>Arterys Inc. </strong>touted <a href="https://www.prnewswire.com/news-releases/arterys-receives-first-fda-clearance-for-broad-oncology-imaging-suite-with-deep-learning-300599275.html"><strong>510(k) clearance</strong></a> for its Artyrys Oncology AI suite, a web-based platform that helps clinicians analyze ARIs and CT scans for signs of potential liver and lung cancer. The tool uses deep learning algorithms to expedite interpretation of these images.</p> <div style="position: relative; display: block; max-width: 100%;"> <div style="padding-top: 56.25%;"> <iframe allow="encrypted-media" allowfullscreen="" mozallowfullscreen="" src="//players.brightcove.net/1824526989001/default_default/index.html?videoId=5856133222001" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;" webkitallowfullscreen=""></iframe></div> </div> <style type="text/css"> <!--/*--><![CDATA[/* ><!--*/ .jumbotron{ background-image: url("http://www.healthcareitnews.com/sites/default/files/u2556/AIJumbotron.jpg"); background-size: cover; color: white; } .jumbotron h2{ color: white; } /*--><!]]>*/ </style><div class="jumbotron"> <h2>Focus on Artificial Intelligence</h2> <p>In November, we take a deep dive into AI and machine learning.</p> <p><input class="btn btn-danger btn-lg" in="" onclick="location.href = 'https://www.healthcareitnews.com/projects/ai-and-machine-learning';" value="Learn more" /></p> </div> </div></div></div> <!-- THEME DEBUG --> <!-- CALL: theme('paragraphs_items') --> <!-- FILE NAME SUGGESTIONS: * paragraphs-items--field-enterprise-taxonomy--full.tpl.php * paragraphs-items--field-enterprise-taxonomy.tpl.php x paragraphs-items.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> <div class="paragraphs-items paragraphs-items-field-enterprise-taxonomy paragraphs-items-field-enterprise-taxonomy-full paragraphs-items-full"> <div class="label-above">Enterprise Taxonomy:&nbsp;</div> <!-- THEME DEBUG --> <!-- CALL: theme('entity') --> <!-- FILE NAME SUGGESTIONS: * ds-reset--paragraphs-item--12858.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy-full.tpl.php * ds-reset--paragraphs-item-enterprise-taxonomy.tpl.php * ds-reset--paragraphs-item-full.tpl.php * ds-reset--paragraphs-item.tpl.php x ds-reset.tpl.php * paragraphs-item--12858.tpl.php * paragraphs-item--enterprise-taxonomy--full.tpl.php * paragraphs-item--enterprise-taxonomy.tpl.php * paragraphs-item.tpl.php * entity.tpl.php --> <!-- BEGIN OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> <!-- END OUTPUT from 'sites/all/modules/contrib/ds/layouts/ds_reset/ds-reset.tpl.php' --> </div> <!-- END OUTPUT from 'sites/all/modules/contrib/paragraphs/theme/paragraphs-items.tpl.php' --> </description> <pubDate>Thu, 15 Nov 2018 21:07:51 +0000</pubDate> <dc:creator>dmuoio</dc:creator> <guid isPermaLink="false">145274 at https://www.mobihealthnews.com</guid> <comments>https://www.mobihealthnews.com/content/roundup-12-healthcare-algorithms-cleared-fda#comments</comments> </item> </channel> </rss>